AMS Guidelines - klimik.org.tr€¦ · Germany-Austria 1 Antimicrobial Stewardship, ESGAP October...

Post on 19-Apr-2020

5 views 0 download

Transcript of AMS Guidelines - klimik.org.tr€¦ · Germany-Austria 1 Antimicrobial Stewardship, ESGAP October...

AMS Guidelines: USA

Germany-Austria

1

Antimicrobial Stewardship, ESGAP October 2017, Istanbul

Özlem Kurt Azap

Başkent University Faculty of Medicine

Infectious Diseases and Clinical Microbiology Dept.

Antimicrobial Stewardship, ESGAP October 2017, Istanbul

2

Antimicrobial Stewardship, ESGAP October 2017, Istanbul

3

• 2007, IDSA, Antimicrobial stewardship guideline

• 2014, CDC, Core elements of hospital antimicrobial stewardship programs

• 2015, White House, National Action Plan for Combating Antibiotic Resistant Bacteria

• 2016

Antimicrobial Stewardship, ESGAP October 2017, Istanbul

4

In USA…

Antimicrobial Stewardship, ESGAP October 2017, Istanbul

5

Antimicrobial Stewardship, ESGAP October 2017, Istanbul

6

Total # recommendations: 28 # strong recommendations: 5 # weak recommendations: 18

# good practice recommendations: 5

Antimicrobial Stewardship, ESGAP October 2017, Istanbul

7

Antimicrobial Stewardship, ESGAP October 2017, Istanbul 8

STRONG

WEAK

Antimicrobial Stewardship, ESGAP October 2017, Istanbul

9

Antimicrobial Stewardship, ESGAP October 2017, Istanbul

10

Antimicrobial Stewardship, ESGAP October 2017, Istanbul

11

GOOD PRACTICE recommendation

Strong recommendations

Antimicrobial Stewardship, ESGAP October 2017, Istanbul

12

Weak recommendations

Antimicrobial Stewardship, ESGAP October 2017, Istanbul 13

Weak recommendations

Antimicrobial Stewardship, ESGAP October 2017, Istanbul

14

Good practice recommendations

Antimicrobial Stewardship, ESGAP October 2017, Istanbul

17

Strong recommendations

Antimicrobial Stewardship, ESGAP October 2017, Istanbul

18

Antimicrobial Stewardship, ESGAP October 2017, Istanbul

19

Which method? Preauthorization? Prospective audit and feedback?

Implementing one of them is better than doing nothing!

Antimicrobial Stewardship, ESGAP October 2017, Istanbul

20

Advantages…. Disadvantages….

Preauthorization

Faster reductions in inappropriate antibiotic use

Optimized empirical choices

Culture results are more commonly encountered while prescribing antibiotics

The cost of antibiotics are decreased

The direct “control” of antibiotics are obtained

Antimicrobial Stewardship, ESGAP October 2017, Istanbul 21

Advantages

Prospective audit and feedback ASP becomes more visible, helps building collegial relationships

Prescribers face more clinical data

Flexibility in timing of recommendations

Can be done less than daily

Educational benefit

Prescriber autonomy

Preauthorization Only restricted agents

Loss of prescriber autonomy

Delay in treatment

Potential for manipulation

Shift to other antibiotics

...

Antimicrobial Stewardship, ESGAP October 2017, Istanbul

22

Disadvantages

Prospective audit and feedback Compliance voluntary

Labour intensive

Method of feedback is important

Reluctance to change therapy

It takes longer to achieve reductions in antibiotic use

...

Treatment durations

Antimicrobial Stewardship, ESGAP October 2017, Istanbul

23

The shortest effective duration is the best!

Antimicrobial Stewardship, ESGAP October 2017, Istanbul

24

Shorter vs Longer duration of antibiotics

Oral treatment

Antimicrobial Stewardship, ESGAP October 2017, Istanbul

25

Oral treatment Initial therapy

Sequential therapy after iv usage

Advantages Lower cost

Shorter hospital stay

PK monitoring and adjustment program

Antimicrobial Stewardship, ESGAP October 2017, Istanbul

26

PK monitoring programs for aminoglycosides

C.difficile

Antimicrobial Stewardship, ESGAP October 2017, Istanbul

27

Avoidance of antibiotics with high risk for C.difficile

Infection control measures

Weak recommendations

Antimicrobial Stewardship, ESGAP October 2017, Istanbul

28

Implementing AMS for spesific infectious diesases syndromes

Antimicrobial Stewardship, ESGAP October 2017, Istanbul

29

Community acquired pneumonia

Hospital acquired pneumonia

Cellulitis Asymptomatic bacteriuria ……

Which measures?

Antimicrobial Stewardship, ESGAP October 2017, Istanbul

30

Process measures Excess days of therapy Duration of therapy Compliance with algorithms Treatment revision based on

microbiological data Switch to oral therapy

Outcome measures Length of hospital stay 30 day mortality Adverse events due to atbs: C.difficile inf ..etc Clinical failure, recurrent infection

Antimicrobial Stewardship, ESGAP October 2017, Istanbul

31

Stratified antibiograms

Antimicrobial susceptibility data based on departments, samples….etc

Antibiotic cycling

Antimicrobial Stewardship, ESGAP October 2017, Istanbul

32

Antibiotic cycling is NOT RECOMMENDED!

Rapid diagnosis: Procalcitonin, viral antigen tests, fungal biomarkers,

molecular methods

Antimicrobial Stewardship, ESGAP October 2017, Istanbul

33

Monitoring antibiotic use: DDD or DOT ?

Antimicrobial Stewardship, ESGAP October 2017, Istanbul

34

DOT: Days of Therapy Not impacted by dose adjustments; can be used both for adults and pediatric patients

CDC requires DOT

Patient-level antibiotic data is required; not feasible at every facility

DDD: Daily Defined Dose Recommended by WHO

Easier than DOT

Widely used and offers comparability

Limited use in pediatrics

Stop orders

Antimicrobial Stewardship, ESGAP October 2017, Istanbul

35

Good practice recommendations

Antimicrobial Stewardship, ESGAP October 2017, Istanbul

36

‘End of life antibiotic treatment’

Antimicrobial Stewardship, ESGAP October 2017, Istanbul

37

In terminally ill patients, ASPs should support clinicians in the decision of antibiotic treatment

In Europe…

• 2001, European Comission

• 2010, European Community, Antimicrobial resistance surveillance and monitoring antibiotic consumption

Antimicrobial Stewardship, ESGAP October 2017, Istanbul

38

Antimicrobial Stewardship, ESGAP October 2017, Istanbul

39

Antimicrobial Stewardship, ESGAP October 2017, Istanbul

40

Antimicrobial Stewardship, ESGAP October 2017, Istanbul

41

Recommendations: # A: 31 # B: 11 # C: 2

The team should consist of…

Antimicrobial Stewardship, ESGAP October 2017, Istanbul

42

0.5 FTE for 250 beds FTE: Full time equivalent

Infectious diseases specialist Clinical pharmacist

Microbiology specialist Epidemiyologist Infection control consultant

Surveillance

Antimicrobial Stewardship, ESGAP October 2017, Istanbul 43

Resistance data should be accessible at least on yearly basis

Resistance data should be reported on department basis, sample basis..etc

Surveilance culture results should be reported seperately

Point prevelance surveys

Antibiotic consumption data: by AB class, top 5 or 10

Number of cultures per 1000 patient days: Blood, urine..

Antimicrobial Stewardship, ESGAP October 2017, Istanbul

44

Quarterly use density (RDD/100patient days)

Targeted proactive audits of antiinfective use

Antimicrobial Stewardship, ESGAP October 2017, Istanbul 45

Point prevalance surveys Antibiotic use for Surgical prophylaxis

Bacteremia

Pneumonia at the Emergency Department

Sequential therapy; PE to oral

Hospital formulary is important!

Antimicrobial Stewardship, ESGAP October 2017, Istanbul

46

Treatment optimisation

Antimicrobial Stewardship, ESGAP October 2017, Istanbul

47

Optimisation of treatment does not necessarily mean de-escalation; sometimes requires escalation

Evaluation at 48-72 hours of therapy

Prolonged infusion of beta lactams…etc

TDM of antibiotics

Computerised information technology

Antimicrobial Stewardship, ESGAP October 2017, Istanbul

48

Treatment guidelines Hospital formulary Surveillance results ….

should be readily electronically accessible

Gram negatif bakteriler için

ANTİMİKROBİYAL YÖNETİM REHBERİ

Hazırlayan: KLİMİK DERNEĞİ

Antimicrobial Stewardship, ESGAP October 2017, Istanbul

49